Literature DB >> 24492846

Genome recognition by MYC.

Arianna Sabò1, Bruno Amati.   

Abstract

MYC dimerizes with MAX to bind DNA, with a preference for the E-box consensus CACGTG and several variant motifs. In cells, MYC binds DNA preferentially within transcriptionally active promoter regions. Although several thousand promoters are bound under physiological (low MYC) conditions, these represent only a fraction of all accessible, active promoters. MYC overexpression-as commonly observed in cancer cells-leads to invasion of virtually all active promoters, as well as of distal enhancer elements. We summarize here what is currently known about the mechanisms that may guide this process. We propose that binding site recognition is determined by low-affinity protein-protein interactions between MYC/MAX dimers and components of the basal transcriptional machinery, other chromatin-associated protein complexes, and/or DNA-bound transcription factors. DNA binding occurs subsequently, without an obligate requirement for sequence recognition. Local DNA scanning then leads to preferential stabilization of the MYC/MAX dimer on high-affinity DNA elements. This model is consistent with the invasion of all active promoters that occurs at elevated MYC levels, but posits that important differences in affinity persist between physiological target sites and the newly invaded elements, which may not all be bound in a productive regulatory mode. The implications of this model for transcriptional control by MYC in normal and cancer cells are discussed in the light of the latest literature.

Entities:  

Mesh:

Year:  2014        PMID: 24492846      PMCID: PMC3904094          DOI: 10.1101/cshperspect.a014191

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  128 in total

1.  Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter.

Authors:  C Bouchard; O Dittrich; A Kiermaier; K Dohmann; A Menkel; M Eilers; B Lüscher
Journal:  Genes Dev       Date:  2001-08-15       Impact factor: 11.361

2.  The mechanism of discrimination between cognate and non-specific DNA by dimeric b/HLH/LZ transcription factors.

Authors:  Simon Sauvé; Jean-François Naud; Pierre Lavigne
Journal:  J Mol Biol       Date:  2006-10-19       Impact factor: 5.469

3.  Backbone dynamics of sequence specific recognition and binding by the yeast Pho4 bHLH domain probed by NMR.

Authors:  J W Cave; W Kremer; D E Wemmer
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

4.  The Notch1/c-Myc pathway in T cell leukemia.

Authors:  Vishva Mitra Sharma; Kyle M Draheim; Michelle A Kelliher
Journal:  Cell Cycle       Date:  2007-04-11       Impact factor: 4.534

5.  Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters.

Authors:  Alfred S L Cheng; Victor X Jin; Meiyun Fan; Laura T Smith; Sandya Liyanarachchi; Pearlly S Yan; Yu-Wei Leu; Michael W Y Chan; Christoph Plass; Kenneth P Nephew; Ramana V Davuluri; Tim H-M Huang
Journal:  Mol Cell       Date:  2006-02-03       Impact factor: 17.970

6.  E-box-independent regulation of transcription and differentiation by MYC.

Authors:  Iris Uribesalgo; Marcus Buschbeck; Arantxa Gutiérrez; Sophia Teichmann; Santiago Demajo; Bernd Kuebler; Josep F Nomdedéu; Juan Martín-Caballero; Guglielmo Roma; Salvador Aznar Benitah; Luciano Di Croce
Journal:  Nat Cell Biol       Date:  2011-10-23       Impact factor: 28.824

7.  Transcriptional repression: the dark side of myc.

Authors:  Barbara Herkert; Martin Eilers
Journal:  Genes Cancer       Date:  2010-06

8.  Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max.

Authors:  B Amati; S Dalton; M W Brooks; T D Littlewood; G I Evan; H Land
Journal:  Nature       Date:  1992-10-01       Impact factor: 49.962

9.  Analysis of Myc bound loci identified by CpG island arrays shows that Max is essential for Myc-dependent repression.

Authors:  Daniel Y L Mao; John D Watson; Pearlly S Yan; Dalia Barsyte-Lovejoy; Fereshteh Khosravi; W Wei-Lynn Wong; Peggy J Farnham; Tim H-M Huang; Linda Z Penn
Journal:  Curr Biol       Date:  2003-05-13       Impact factor: 10.834

10.  A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells.

Authors:  Zirong Li; Sara Van Calcar; Chunxu Qu; Webster K Cavenee; Michael Q Zhang; Bing Ren
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-13       Impact factor: 11.205

View more
  51 in total

Review 1.  MYC: connecting selective transcriptional control to global RNA production.

Authors:  Theresia R Kress; Arianna Sabò; Bruno Amati
Journal:  Nat Rev Cancer       Date:  2015-09-18       Impact factor: 60.716

2.  The T-Box factor TBX3 is important in S-phase and is regulated by c-Myc and cyclin A-CDK2.

Authors:  Tarryn Willmer; Jade Peres; Shaheen Mowla; Amaal Abrahams; Sharon Prince
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 3.  MYC and transcription elongation.

Authors:  Peter B Rahl; Richard A Young
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

Review 4.  An overview of MYC and its interactome.

Authors:  Maralice Conacci-Sorrell; Lisa McFerrin; Robert N Eisenman
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

Review 5.  Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.

Authors:  Daniel Diolaiti; Lisa McFerrin; Patrick A Carroll; Robert N Eisenman
Journal:  Biochim Biophys Acta       Date:  2014-05-22

6.  The cancer genome: from structure to function.

Authors:  Ad Geurts van Kessel
Journal:  Cell Oncol (Dordr)       Date:  2014-06       Impact factor: 6.730

7.  Error-prone translesion synthesis past DNA-peptide cross-links conjugated to the major groove of DNA via C5 of thymidine.

Authors:  Susith Wickramaratne; Emily J Boldry; Charles Buehler; Yen-Chih Wang; Mark D Distefano; Natalia Y Tretyakova
Journal:  J Biol Chem       Date:  2014-11-12       Impact factor: 5.157

Review 8.  Long non-coding RNAs and MYC association in hematological malignancies.

Authors:  Leonidas Benetatos; Agapi Benetatou; Georgios Vartholomatos
Journal:  Ann Hematol       Date:  2020-07-04       Impact factor: 3.673

Review 9.  Therapeutic strategies to inhibit MYC.

Authors:  Michael R McKeown; James E Bradner
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-01       Impact factor: 6.915

Review 10.  MYC cofactors: molecular switches controlling diverse biological outcomes.

Authors:  Stephen R Hann
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-17       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.